Ewing Sarcoma
Cross-source consensus on Ewing Sarcoma from 1 sources and 3 claims.
1 sources · 3 claims
How it works
Risks & contraindications
Where it comes from
Highlighted claims
- Ewing sarcoma is a rare pediatric bone cancer. — An Analytical Approach for Insulin-like Growth Factor Receptor 1 and Mammalian Target of Rapamycin Blockades in Ewing Sarcoma
- Ewing sarcoma often develops either de novo or acquired resistance to targeted therapies. — An Analytical Approach for Insulin-like Growth Factor Receptor 1 and Mammalian Target of Rapamycin Blockades in Ewing Sarcoma
- Ewing sarcoma growth and metastasis can continue when single-component inhibition is bypassed by feedback signaling cascades. — An Analytical Approach for Insulin-like Growth Factor Receptor 1 and Mammalian Target of Rapamycin Blockades in Ewing Sarcoma